Literature DB >> 21983962

Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesis.

Yukiji Takeda1, Sandra Costa, Estelle Delamarre, Carmen Roncal, Rodrigo Leite de Oliveira, Mario Leonardo Squadrito, Veronica Finisguerra, Sofie Deschoemaeker, Françoise Bruyère, Mathias Wenes, Alexander Hamm, Jens Serneels, Julie Magat, Tapan Bhattacharyya, Andrey Anisimov, Benedicte F Jordan, Kari Alitalo, Patrick Maxwell, Bernard Gallez, Zhen W Zhuang, Yoshihiko Saito, Michael Simons, Michele De Palma, Massimiliano Mazzone.   

Abstract

PHD2 serves as an oxygen sensor that rescues blood supply by regulating vessel formation and shape in case of oxygen shortage. However, it is unknown whether PHD2 can influence arteriogenesis. Here we studied the role of PHD2 in collateral artery growth by using hindlimb ischaemia as a model, a process that compensates for the lack of blood flow in case of major arterial occlusion. We show that Phd2 (also known as Egln1) haplodeficient (Phd2(+/-)) mice displayed preformed collateral arteries that preserved limb perfusion and prevented tissue necrosis in ischaemia. Improved arteriogenesis in Phd2(+/-) mice was due to an expansion of tissue-resident, M2-like macrophages and their increased release of arteriogenic factors, leading to enhanced smooth muscle cell (SMC) recruitment and growth. Both chronic and acute deletion of one Phd2 allele in macrophages was sufficient to skew their polarization towards a pro-arteriogenic phenotype. Mechanistically, collateral vessel preconditioning relied on the activation of canonical NF-κB pathway in Phd2(+/-) macrophages. These results unravel how PHD2 regulates arteriogenesis and artery homeostasis by controlling a specific differentiation state in macrophages and suggest new treatment options for ischaemic disorders.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21983962      PMCID: PMC4659699          DOI: 10.1038/nature10507

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  34 in total

1.  Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity.

Authors:  Eoin P Cummins; Edurne Berra; Katrina M Comerford; Amandine Ginouves; Kathleen T Fitzgerald; Fergal Seeballuck; Catherine Godson; Jens E Nielsen; Paul Moynagh; Jacques Pouyssegur; Cormac T Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-17       Impact factor: 11.205

Review 2.  The interplay between macrophages and angiogenesis in development, tissue injury and regeneration.

Authors:  Silvia Nucera; Daniela Biziato; Michele De Palma
Journal:  Int J Dev Biol       Date:  2011       Impact factor: 2.203

3.  Macrophage regulation of tumor angiogenesis: implications for cancer therapy.

Authors:  Mario Leonardo Squadrito; Michele De Palma
Journal:  Mol Aspects Med       Date:  2011-05-01

4.  Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Authors:  P Jaakkola; D R Mole; Y M Tian; M I Wilson; J Gielbert; S J Gaskell; A von Kriegsheim; H F Hebestreit; M Mukherji; C J Schofield; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

5.  Prolyl hydroxylase EGLN3 regulates skeletal myoblast differentiation through an NF-kappaB-dependent pathway.

Authors:  Jian Fu; Mark B Taubman
Journal:  J Biol Chem       Date:  2010-01-10       Impact factor: 5.157

6.  Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization.

Authors:  Massimiliano Mazzone; Daniela Dettori; Rodrigo Leite de Oliveira; Sonja Loges; Thomas Schmidt; Bart Jonckx; Ya-Min Tian; Anthony A Lanahan; Patrick Pollard; Carmen Ruiz de Almodovar; Frederik De Smet; Stefan Vinckier; Julián Aragonés; Koen Debackere; Aernout Luttun; Sabine Wyns; Benedicte Jordan; Alberto Pisacane; Bernard Gallez; Maria Grazia Lampugnani; Elisabetta Dejana; Michael Simons; Peter Ratcliffe; Patrick Maxwell; Peter Carmeliet
Journal:  Cell       Date:  2009-02-12       Impact factor: 41.582

7.  Prolyl hydroxylase-3 is down-regulated in colorectal cancer cells and inhibits IKKbeta independent of hydroxylase activity.

Authors:  Jing Xue; Xuebing Li; Shi Jiao; Ye Wei; Guohao Wu; Jing Fang
Journal:  Gastroenterology       Date:  2009-09-26       Impact factor: 22.682

8.  The two faces of IKK and NF-kappaB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion.

Authors:  Lee-Wei Chen; Laurence Egan; Zhi-Wei Li; Florian R Greten; Martin F Kagnoff; Michael Karin
Journal:  Nat Med       Date:  2003-04-07       Impact factor: 53.440

9.  Tumor vasculature is regulated by PHD2-mediated angiogenesis and bone marrow-derived cell recruitment.

Authors:  Denise A Chan; Tiara L A Kawahara; Patrick D Sutphin; Howard Y Chang; Jen-Tsan Chi; Amato J Giaccia
Journal:  Cancer Cell       Date:  2009-06-02       Impact factor: 31.743

10.  An antiinflammatory role for IKKbeta through the inhibition of "classical" macrophage activation.

Authors:  Carol Ho Yan Fong; Magali Bebien; Arnaud Didierlaurent; Ruth Nebauer; Tracy Hussell; David Broide; Michael Karin; Toby Lawrence
Journal:  J Exp Med       Date:  2008-05-19       Impact factor: 14.307

View more
  131 in total

Review 1.  Molecular oxygen sensing: implications for visceral surgery.

Authors:  Judit Kiss; Johanna Kirchberg; Martin Schneider
Journal:  Langenbecks Arch Surg       Date:  2012-03-07       Impact factor: 3.445

Review 2.  Macrophage plasticity and polarization: in vivo veritas.

Authors:  Antonio Sica; Alberto Mantovani
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

Review 3.  Targeting vascular and leukocyte communication in angiogenesis, inflammation and fibrosis.

Authors:  Johan Kreuger; Mia Phillipson
Journal:  Nat Rev Drug Discov       Date:  2015-11-27       Impact factor: 84.694

4.  Macrophage Polarization during Murine Lyme Borreliosis.

Authors:  Carrie E Lasky; Rachel M Olson; Charles R Brown
Journal:  Infect Immun       Date:  2015-04-13       Impact factor: 3.441

5.  Profilin phosphorylation as a VEGFR effector in angiogenesis.

Authors:  Michael Simons; Martin A Schwartz
Journal:  Nat Cell Biol       Date:  2012-10       Impact factor: 28.824

6.  Myeloid PTEN deficiency protects livers from ischemia reperfusion injury by facilitating M2 macrophage differentiation.

Authors:  Shi Yue; Jianhua Rao; Jianjun Zhu; Ronald W Busuttil; Jerzy W Kupiec-Weglinski; Ling Lu; Xuehao Wang; Yuan Zhai
Journal:  J Immunol       Date:  2014-04-25       Impact factor: 5.422

7.  Skeletal myofiber VEGF is essential for the exercise training response in adult mice.

Authors:  Hamid Delavar; Leonardo Nogueira; Peter D Wagner; Michael C Hogan; Daniel Metzger; Ellen C Breen
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-02-12       Impact factor: 3.619

8.  Endothelial nuclear factor-κB-dependent regulation of arteriogenesis and branching.

Authors:  Daniela Tirziu; Irina M Jaba; Pengchun Yu; Bruno Larrivée; Brian G Coon; Brunella Cristofaro; Zhen W Zhuang; Anthony A Lanahan; Martin A Schwartz; Anne Eichmann; Michael Simons
Journal:  Circulation       Date:  2012-10-22       Impact factor: 29.690

9.  HIF-1-PHD2 axis controls expression of syndecan 4 in nucleus pulposus cells.

Authors:  Nobuyuki Fujita; Yuichiro Hirose; Cassie M Tran; Kazuhiro Chiba; Takeshi Miyamoto; Yoshiaki Toyama; Irving M Shapiro; Makarand V Risbud
Journal:  FASEB J       Date:  2014-02-20       Impact factor: 5.191

10.  Pentraxin-3 Attenuates Renal Damage in Diabetic Nephropathy by Promoting M2 Macrophage Differentiation.

Authors:  Huaibin Sun; Jun Tian; Wanhua Xian; Tingting Xie; Xiangdong Yang
Journal:  Inflammation       Date:  2015-10       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.